Strategic CIO — Pharma & Biotech transformation & growth (Australia)

Position overview

Gladwin International Leadership Advisors is representing a confidential organisation in Pharmaceuticals & Biotechnology on a senior CIO leadership mandate anchored in Australia. The remit explicitly spans Canada, Middle East, Singapore.

This is a strategic transformation mandate at CXO level — equal parts operating leadership, change orchestration, and investor / board narrative ownership.

Success here is less about charisma in town halls and more about judgment in investment committees and talent decisions.

Context you will inherit

• Market & sector: Digital transformation in pharma — AI-assisted drug discovery, clinical trial optimisation, and commercial analytics require technology-fluent leaders in a traditionally conservative sector
• Geographic spine: Primary hub Australia with explicit corridor responsibility across Canada, Middle East, Singapore.
• Organisation stage: Portfolio under review: non-core assets, JVs, and country footprints are actively questioned each planning cycle.
• Stakeholders: Stakeholders span board or regional executive committee, global functional heads, JV partners, and strategic account buyers.
• Secondary lens: USFDA and EMA compliance — finding quality and regulatory leaders who can restore and maintain approval status for facilities under import alert or warning letter, one of the sector's most acute leadership demands

The mandate (12–24 month arc)

1. Service catalogue: Clear offerings, owners, and SLAs — reduce bespoke IT arrangements that don’t scale.
2. Major incident command: Practised playbooks, comms templates, and executive briefing discipline.
3. Technical debt register: Visible to leadership; fund pay-down in proportion to risk and customer impact.
4. License optimisation: True-up discipline and shelf-ware elimination — partner with procurement.
5. Regulatory projects: Ring-fence capacity for supervisor-driven change without starving business roadmap.
6. Geographic IT: Harmonise standards across hubs while respecting data residency and local support needs.

Responsibilities (representative)

• Own IT service delivery, run cost, and major business system programmes.
• Partner with business on digital initiatives — clear roles vs. product/engineering where split.
• Lead infrastructure, cloud, and workplace technology strategy.
• Co-own cyber resilience with CISO; prioritise by business criticality.
• Rationalise application portfolio — retire, replace, or integrate duplicates.

Leadership profile

• Business systems: Large programme delivery — ERP, core platforms, or digital workplace at scale.
• Communication: Executive presence in English; additional languages valued where market-relevant.
• Judgment: High signal-to-noise under pressure; ethical clarity; willingness to halt initiatives that break risk appetite.
• Education: Strong undergraduate grounding; MBA / advanced degree / professional qualification common at this level.
• Geographic muscle: Comfort operating from Australia with regular engagement across Canada, Middle East.

Team & culture

You inherit a mixed-tenure team — pockets of excellence beside roles that need upgrade. The mandate is to raise the bar without demoralising the organisation: clear standards, fair process, and visible wins that prove the new pace is achievable.

Success measures (examples)

• Growth quality: Mix of recurring revenue, new logos, and cross-sell — not volume for its own sake.
• Productivity: Unit cost, automation savings, or throughput improvements with audited baselines.
• Customer: NPS / CSAT where tracked; contract renewals; reference-ability in strategic accounts.
• Franchise: Clean compliance record; reputation stability in industry and government forums.

First 90 days (orientation arc)

• Days 1–30: Listening tour — customers, regulators (as appropriate), top team 1:1s, and unfiltered view of numbers; pause major reorganisation.
• Days 30–60: Publish a short memo on priorities, non-goals, and decision rights; align executive committee on three enterprise bets.
• Days 60–90: Lock operating cadence; fill or upgrade one to two critical seats; deliver one visible win (customer, cost, or culture).
• Commission a pragmatic view of data, cyber, and automation posture; sponsor one bounded pilot with ROI hypothesis.
• Establish escalation discipline with matrix partners — fewer meetings, clearer decision logs.

Stakeholder map (illustrative)

• Internal: CEO or regional president, CFO, risk / legal, CHRO, CIO or CDO, business GMs, internal audit.
• External: Strategic accounts, channel partners, industry associations, regulators (where material).
• Owners: PE operating partners, promoter office, or public investors — pace and clarity matter as much as vision.

Travel & mobility

Role requires face-to-face presence in the primary hub with regular regional travel; remote-only not viable.

Compensation

Market-aligned CIO remuneration in Pharmaceuticals & Biotechnology with performance linkage; sign-on and relocation considered for exceptional fits.

Application status

This mandate is no longer accepting new applications. The search progressed through Q4 2025 and closed for submissions in February 2026. We retain this posting for transparency on the type of leadership work we carry in Pharmaceuticals & Biotechnology and Australia. For similar active mandates, browse open roles or submit a general profile through executive search inquiry.

Reference: pharmaceuticals-biotech · CIO · Australia · Gladwin International Leadership Advisors